Announcements Trials
Browse Landscape

Phase

Phase NA 5

Status

Completed 3Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 4NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 10Tumor-Agnostic 5Other solid neoplasm 3Lymphoid 3Gynecologic 3Gastrointestinal 3Other 2Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Myeloid 1Head & Neck 1Dermatologic 1CNS 1

Conditions

Neoplasms 4Neoplasm Metastasis 1

Interventions

pembrolizumab 94Paclitaxel 85Gemcitabine 83Carboplatin 79Docetaxel 60Cisplatin 58Bevacizumab 58Nivolumab 56Fluorouracil 47Capecitabine 46Magnetic Resonance Spectroscopy 44Radiotherapy 41Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 37Pemetrexed 34Leucovorin 34Biopsy 34atezolizumab 33Cetuximab 32Standard of Care 31Trastuzumab 28Cyclophosphamide 28Radiosurgery 27Blood Specimen Collection 27Specimen Handling 26Sorafenib 26Ipilimumab 26Everolimus 26olaparib 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × Mindfulness × Tumor-Agnostic × Clear all
NCT05470010 2026-03-27

SEAMLESS

Canadian Cancer Trials Group

Phase NA Recruiting
345 enrolled
Tumor-Agnostic

Neoplasms

NCT07124481 2025-08-15

EarlyMind

Isala

Phase NA Not yet recruiting
208 enrolled
Tumor-Agnostic

Neoplasms

NCT03557762 2022-05-23

The SEAMLESS Study: Smartphone App-based Mindfulness for Cancer Survivors

University of Calgary

Phase NA Completed
83 enrolled
Tumor-Agnostic

Neoplasms

NCT03446092 2022-05-12

Mindfulness for People With Incurable Cancer

Lancaster University

Phase NA Completed
3 enrolled
Tumor-Agnostic

Neoplasms

NCT03257007 2020-08-12

MEANING

Indiana University

Phase NA Completed
108 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡